RSV vaccine approved for older Australians

Australian Community Media 2024-01-22

Views 7.7K

Older Australians will soon have access to a vaccine for respiratory syncytial virus RSV through a private prescription. The Therapeutic Goods Administration has approved AREXVY vaccine for those over 60.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
RSV vaccine approved for older Australians
play
00:47

RSV vaccine approved for older Australians
AWANI Pagi: Risiko Respiratory Syncytial Virus (RSV) dalam kalangan kanak-kanak
play
27:58

AWANI Pagi: Risiko Respiratory Syncytial Virus (RSV) dalam kalangan kanak-kanak
Everything We Know About RSV, or Respiratory Syncytial Virus - 1breakingnews.com
play
04:55

Everything We Know About RSV, or Respiratory Syncytial Virus - 1breakingnews.com
What you need to know about RSV (respiratory syncytial virus)
play
01:10

What you need to know about RSV (respiratory syncytial virus)
Respiratory Syncytial Virus (RSV) Concern Extends Beyond Children
play
01:11

Respiratory Syncytial Virus (RSV) Concern Extends Beyond Children
First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines
play
01:23

First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines
First RSV Vaccine For Infants Approved By CDC And FDA: Other Top Vaccines
play
02:04

First RSV Vaccine For Infants Approved By CDC And FDA: Other Top Vaccines
Respiratory Syncytial Virus Sends 75,000+ Kids to Hospital each Year
play
02:15

Respiratory Syncytial Virus Sends 75,000+ Kids to Hospital each Year
Ano nga ba ang respiratory syncytial virus?
play
09:05

Ano nga ba ang respiratory syncytial virus?
Read Respiratory Syncytial Virus: Prevention Diagnosis and Treatment (Virology Research Progress)
play
00:08

Read Respiratory Syncytial Virus: Prevention Diagnosis and Treatment (Virology Research Progress)
Maternal RSV vaccine Abrysvo approved for third trimester of pregnancy - 1breakingnews.com
play
00:23

Maternal RSV vaccine Abrysvo approved for third trimester of pregnancy - 1breakingnews.com
DOST preparing for trials on mixing and matching COVID-19 vaccines; DOST: 4 COVID-19 vaccines approved by FDA; OCTA: NCR should remain under GCQ classification despite improving stats
play
02:38

DOST preparing for trials on mixing and matching COVID-19 vaccines; DOST: 4 COVID-19 vaccines approved by FDA; OCTA: NCR should remain under GCQ classification despite improving stats